Overview of AL Amyloidosis
The Inaugural Meeting of the forum provided an overview of AL amyloidosis, and addressed the challenges in clinical trial design for such a complex, multi-systemic disease in a heterogenous population. The meeting established the priorities for future forums.
Understanding AL Amyloidosis
November 30, 2019
Novel Endpoints and Analyses
In this series of meetings addressing one of the priority areas identified at the inaugural meeting, the Amyloidosis Forum focuses on Novel Endpoints and Analyses for Clinical Trials in AL amyloidosis.
Novel Endpoints and Analyses in Multisystemic Rare Disease Trials
October 15, 2020
Considerations for Novel Endpoint Development in AL Amyloidosis
January 22, 2021